714
Participants
Start Date
January 31, 2015
Primary Completion Date
August 31, 2016
Study Completion Date
June 29, 2017
Bremelanotide
A melanocortin agonist and synthetic peptide analog of the naturally occurring hormone alpha-MSH (melanocyte-stimulating hormone)
Placebo
Placebo
Palatin Clinical Site 282, Rochester
Palatin Clinical Site 240, Pittsburgh
Palatin Clinical Site 267, Allentown
Palatin Clinical Site 234, Philadelphia
Palatin Clinical Site 202, Washington D.C.
Palatin Clinical Site 283, Rockville
Palatin Clinical Site 222, Lutherville
Palatin Clinical Site 257, Annapolis
Palatin Clinical Site 213, Richmond
Palatin Clinical Site 268, Richmond
Palatin Clinical Site 205, Norfolk
Palatin Clinical Site 284, Newport News
Palatin Clinical Site 285, Charleston
Palatin Clinical Site 209, Winston-Salem
Palatin Clinical Site 264, Cary
Palatin Clinical Site 206, Raleigh
Palatin Clinical Site 231, Salisbury
Palatin Clinical Site 259, Moncks Corner
Palatin Clinical Site 200, Greer
Palatin Clinical Site 248, Alpharetta
Palatin Clinical Site 263, Atlanta
Palatin Clinical Site 255, Gainesville
Palatin Clinical Site 266, Gainesville
Palatin Clinical Site 261, Oviedo
Palatin Clinical Site 250, Orlando
Palatin Clinical Site 273, Coral Gables
Palatin Clinical Site 204, Aventura
Palatin Clinical Site 236, West Palm Beach
Palatin Clinical Site 224, Jupiter
Palatin Clinical Site 260, Pinellas Park
Palatin Clinical Site 203, Fort Myers
Palatin Clinical Site 242, Birmingham
Palatin Clinical Site 292, Nashville
Palatin Clinical Site 275, Chattanooga
Palatin Clinical Site 274, Memphis
Palatin Clinical Site 216, Jackson
Palatin Clinical Site 287, Flowood
Palatin Clinical Site 286, Paducah
Palatin Clinical Site 246, Columbus
Palatin Clinical Site 232, Cleveland
Palatin Clinical Site 221, Mayfield Heights
Palatin Clinical Site 271, Canton
Palatin Clinical Site 289, Tiffin
Palatin Clinical Site 215, Cincinnati
Palatin Clinical Site 277, Indianapolis
Palatin Clinical Site 245, Saginaw
Palatin Clinical Site 239, Kalamazoo
Palatin Clinical Site 288, Addison
Palatin Clinical Site 252, Chicago
Palatin Clinical Site 201, Chicago
Palatin Clinical Site 280, St Louis
Palatin Clinical Site 244, Kansas City
Palatin Clinical Site 247, Prairie Village
Palatin Clinical Site 220, Lincoln
Palatin Clinical Site 281, Metairie
Palatin Clinical Site 279, Lake Charles
Palatin Clinical Site 207, Hot Springs
Palatin Clinical Site 238, Oklahoma City
Palatin Clinical Site 227, Oklahoma City
Palatin Clinical Site 235, Arlington
Palatin Clinical Site 223, Dallas
Palatin Clinical Site 208, Houston
Palatin Clinical Site 230, Austin
Palatin Clinical Site 212, Denver
Palatin Clinical Site 219, Denver
Palatin Clinical Site 243, Lakewood
Palatin Clinical Site 269, Draper
Palatin Clinical Site 228, West Jordan
Palatin Clinical Site 218, Phoenix
Palatin Clinical Site 254, Tucson
Palatin Clinical Site 276, Albuquerque
Palatin Clinical Site 291, Los Angeles
Palatin Clinical Site 258, Beverly Hills
Palatin Clinical Site 253, Tarzana
Palatin Clinical Site 272, Sherman Oaks
Palatin Clinical Site 210, San Diego
Palatin Clinical Site 251, San Diego
Palatin Clinical Site 256, Garden Grove
Palatin Clinical Site 270, Oakland
Palatin Clinical Site 214, Seattle
Palatin Clinical Site 211, New London
Palatin Clinical Site 229, Waterbury
Palatin Clinical Site 265, Boston
Palatin Clinical Site 217, New Bedford
Palatin Clinical Site 290, Berlin
Palatin Clinical Site 233, Lawrenceville
Palatin Clinical Site 278, Lincoln
Palatin Clinical Site 400, Vancouver
Palatin Clinical Site 405, Greater Sudbury
Palatin Clinical Site 401, Pointe-Claire
Palatin Clinical Site 404, Sherbrooke
Lead Sponsor
Collaborators (1)
AMAG Pharmaceuticals, Inc.
INDUSTRY
Palatin Technologies, Inc
INDUSTRY